학술논문
A phase I, first-in-human study to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of MRG-001 in healthy subjects
Document Type
Article
Author
Source
In Cell Reports Medicine 19 September 2023 4(9)
Subject
Language
ISSN
2666-3791